MICHAEL SETH ALTMAN

Insider Reports History

Location
New York, NY
Signature
/s/ Samuel M. Cohn, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by MICHAEL SETH ALTMAN:

Company Role Class Num Shares Value Price $ Report Date Ownership
ARYA Sciences Acquisition Corp V Chief Financial Officer, Director, 10%+ Owner Class A ordinary shares 499,000 $4,990,000 $10.00 15 Jul 2021 By ARYA Sciences Holdings V
Perceptive Capital Solutions Corp Chief Business Officer, Director, 10%+ Owner Class A ordinary shares 286,250 $2,862,500 $10.00 13 Jun 2024 By Perceptive Capital Solutions Holdings
Nautilus Biotechnology, Inc. Director Stock Option (Right to Buy) 45,000 14 Jun 2024 Direct
Lyra Therapeutics, Inc. Director Stock Option 30,000 13 Jun 2024 Direct
ARYA Sciences Acquisition Corp IV Chief Financial Officer, Director, 10%+ Owner Class A ordinary shares 0 31 Jul 2024 By ARYA Sciences Holdings IV
ARYA Sciences Acquisition Corp IV Chief Financial Officer, Director, 10%+ Owner Class B ordinary shares 0 31 Jul 2024 By ARYA Sciences Holdings IV

Insider Reports Filed by MICHAEL SETH ALTMAN

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ARYD ARYA Sciences Acquisition Corp IV 31 Jul 2024 3 $0 4 Chief Financial Officer, Director, 10%+ Owner 31 Jul 2024, 21:40
NAUT Nautilus Biotechnology, Inc. 14 Jun 2024 1 $0 4 Director 17 Jun 2024, 18:03
LYRA Lyra Therapeutics, Inc. 13 Jun 2024 1 $0 4 Director 14 Jun 2024, 16:10
PCSC Perceptive Capital Solutions Corp 13 Jun 2024 1 $2,862,500 4 Chief Business Officer, Director, 10%+ Owner 13 Jun 2024, 16:37
PCSC Perceptive Capital Solutions Corp 11 Jun 2024 0 $0 3 Chief Business Officer, Director 11 Jun 2024, 17:58
LYRA Lyra Therapeutics, Inc. 30 Jun 2023 1 $0 4 Director 05 Jul 2023, 21:49
NAUT Nautilus Biotechnology, Inc. 15 Jun 2023 1 $0 4 Director 20 Jun 2023, 20:52
LYRA Lyra Therapeutics, Inc. 16 Jun 2022 1 $0 4 Director 21 Jun 2022, 16:06
NAUT Nautilus Biotechnology, Inc. 15 Jun 2022 1 $0 4 Director 17 Jun 2022, 17:43
ARYE ARYA Sciences Acquisition Corp V 15 Jul 2021 1 $4,990,000 4 Chief Financial Officer, Director, 10%+ Owner 15 Jul 2021, 17:53
ARYE ARYA Sciences Acquisition Corp V 12 Jul 2021 0 $0 3 Chief Financial Officer, Director, 10%+ Owner 12 Jul 2021, 20:07
NAUT Nautilus Biotechnology, Inc. 09 Jun 2021 5 $0 4 Director 11 Jun 2021, 17:32
LYRA Lyra Therapeutics, Inc. 26 May 2021 1 $0 4 Director 28 May 2021, 18:28